PUBLICATION

Acute administration of a dopamine D2/D3 receptor agonist alters behavioral and neural parameters in adult zebrafish

Authors
Nabinger, D.D., Altenhofen, S., Buatois, A., Facciol, A., Peixoto, J.V., da Silva, J.M.K., Chatterjee, D., Rübensam, G., Gerlai, R., Bonan, C.D.
ID
ZDB-PUB-230320-38
Date
2023
Source
Progress in neuro-psychopharmacology & biological psychiatry   125: 110753 (Journal)
Registered Authors
Bonan, Carla Denise, Gerlai, Robert T.
Keywords
Dopamine, Glutamate, Quinpirole, Serotonin, Zebrafish behavior
MeSH Terms
  • Animals
  • Brain-Derived Neurotrophic Factor
  • Dopamine/pharmacology
  • Dopamine Agonists*/pharmacology
  • Humans
  • Motor Activity
  • Quinpirole/pharmacology
  • Receptors, Dopamine D3
  • Zebrafish*
PubMed
36934998 Full text @ Prog. Neuropsychopharmacol. Biol. Psychiatry
Abstract
The dopaminergic neurotransmitter system is implicated in several brain functions and behavioral processes. Alterations in it are associated with the pathogenesis of several human neurological disorders. Pharmacological agents that interact with the dopaminergic system allow the investigation of dopamine-mediated cellular and molecular responses and may elucidate the biological bases of such disorders. Zebrafish, a translationally relevant biomedical research organism, has been successfully employed in prior psychopharmacology studies. Here, we evaluated the effects of quinpirole (dopamine D2/D3 receptor agonist) in adult zebrafish on behavioral parameters, brain-derived neurotrophic factor (BDNF) and neurotransmitter levels. Zebrafish received intraperitoneal injections of 0.5, 1.0, or 2.0 mg/kg quinpirole or saline (control group) twice with an inter-injection interval of 48 h. All tests were performed 24 h after the second injection. After this acute quinpirole administration, zebrafish exhibited decreased locomotor activity, increased anxiety-like behaviors and memory impairment. However, quinpirole did not affect social and aggressive behavior. Quinpirole-treated fish exhibited stereotypic swimming, characterized by repetitive behavior followed by immobile episodes. Moreover, quinpirole treatment also decreased the number of BDNF-immunoreactive cells in the zebrafish brain. Analysis of neurotransmitter levels demonstrated a significant increase in glutamate and a decrease in serotonin, while no alterations were observed in dopamine. These findings demonstrate that dopaminergic signaling altered by quinpirole administration results in significant behavioral and neuroplastic changes in the central nervous system of zebrafish. Thus, we conclude that the use of quinpirole administration in adult zebrafish may be an appropriate tool for the analysis of mechanisms underlying neurological disorders related to the dopaminergic system.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping